SRZN ($SRZN) Insider Trading & Smart Money Activity

SRZN · Biotechnology · Latest filing Jun 15, 2026

$SRZN has 7 insider trades on file. Insiders filed 7 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

SRZN insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All SRZN insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Charles WilliamsChief Operating Officer Buy (Grant or award) 1.67K sh $13.51K +2.2%-5.8% Read
Insider Charles WilliamsChief Operating Officer Buy (Grant or award) 1.67K sh $13.51K +2.2%-5.8% —
Insider Craig ParkerChief Executive Officer Buy (Grant or award) 1.62K sh $13.15K +2.2%-5.8% Read
Insider Craig ParkerChief Executive Officer Buy (Grant or award) 1.62K sh $13.15K +2.2%-5.8% —
Insider Maleki Andrew PedrumChief Financial Officer Buy (Grant or award) 607 sh $11.54K +2.2%-5.8% Read
Insider Maleki Andrew PedrumChief Financial Officer Buy (Grant or award) 607 sh $11.54K +2.2%-5.8% —
Insider Yang LiExec. Vice President, Research Buy (Grant or award) 1.67K sh $13.51K +2.2%-5.8% —

1W / 1M / 6M = how SRZN moved from the trade or filing date.

Insider trading in SRZN: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Charles Williams Chief Operating Officer 2 — Jun 15, 2026
Craig Parker Chief Executive Officer 2 — Jun 15, 2026
Maleki Andrew Pedrum Chief Financial Officer 2 — Jun 15, 2026
Yang Li Exec. Vice President, Research 1 — Jun 15, 2026

Frequently asked questions

What is the latest insider trade in SRZN?

Charles Williams, Chief Operating Officer filed a buy (grant or award) of 1.67K sh worth $13.51K on Jun 15, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text